Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Healthcare Innovations from a Patient’s Perspective

Patients, now more than ever, want transparency, agency and access to care. After a global pandemic gave people new perspectives on the level of proactive and reactive care needed to stay healthy and in tune with their healthcare systems, healthcare systems are seeking positive innovations to meet those desires. Kezia Fitzgerald, Chief Innovation Officer and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Patients, now more than ever, want transparency, agency and access to care. After a global pandemic gave people new perspectives on the level of proactive and reactive care needed to stay healthy and in tune with their healthcare systems, healthcare systems are seeking positive innovations to meet those desires.

Kezia Fitzgerald, Chief Innovation Officer and Co-founder of CareAline , understands the importance of those patient needs personally. Fitzgerald spoke with Daniel Litwin on how her healthcare journey led her and her husband to create CareAline, a medical supplies company that provides vascular products and personal protection solutions to healthcare organizations across the country.

For Fitzgerald, creating this organization focused on patient-centric solutions was a passion born from her own experiences.

“I was diagnosed with cancer in 2011, and, shortly after, my daughter was diagnosed with her own cancer,” Fitzgerald said. “So, we were sort of forced into the medical world. And we use that patient perspective when we’re looking at problems in healthcare. Not only do we look at problems patients are facing, but we also look at problems that clinicians are facing day-to-day in their care of patients.”

Something Fitzgerald noticed about some large medical product manufacturers is they may not always bring patient feedback into the product development conversation early enough.

“A lot of times, they wait until a product has a minimal viable product,” Fitzgerald said. “They’ve built something, and then they want to try to test it on patients versus bringing those patients in when they’re talking about the problem at the very beginning. Without bringing in those patients to the table at that time, you’re losing an entire frame of perspective.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512